Specialist
Former C-Level Executive at NHS Digital
Agenda
- Challenges to scaling healthcare apps
- High growth apps
- NHS Digital's agenda and outsourcing trends
Questions
1.
Many interesting health apps seem to be arising across the EU. How would you rate the UK in the context of EU opportunities for these apps?
2.
I’ve seen a few apps come out of France, but not so many in Germany. Why has uptake been slower in these countries?
3.
How important is it for healthcare apps to establish a relationship with the NHS in the UK?
4.
Can you outline the app segments you mentioned with examples?
5.
Do any players comes to mind in the prescription ordering segment?
6.
Which areas of the health sector do you think are most attractive for an investor looking to scale an app?
7.
Which NHS stakeholders would we need to be aware of when thinking about partnering for a horizontal app?
8.
How does the NHS capital allocation process work? Who is directly involved?
9.
How good do you think the fit is between apps that are beginning to get to scale and the digital innovation that the NHS is looking for?
10.
Do you think that a Jeremy Corbyn-led Labour government would change the environment for UK apps?
11.
You provided an introduction to app monetisation, but what revenue streams can you build out with a health app?
12.
I think some French appointment booking apps monetise through charging doctors subscription fees for their services, such as Doctolib. What do you think of this model?
13.
Are GP booking services typically provided by Emis and TPP [The Phoenix Partnership] in the UK or is there a gap for businesses such as Doctolib here?
14.
How do you think about monetising through private medical insurance vs through the NHS in the UK?
15.
How much willingness or cash is there to pay for additional apps among insurers and the NHS in the UK? They’ve already got a big public relationship with Babylon in London.
16.
Is specific budget earmarked for apps in the UK?
17.
What are the challenges of scaling a healthcare app?
18.
Babylon has partnered with quite a few big corporates. Is that necessary or just a nice-to-have?
19.
What are the key challenges and what could go wrong?
20.
What would happen if a patient was not referred by major telemedicine provider when they were supposed to be?
21.
A lot of money is being raised in VC rounds for many healthcare apps. How do you think it makes sense to value an app?
22.
It seems that a few telemedicine apps do relatively similar things. How do you foresee the telemedicine market structure evolving across players such as Babylon and Docly?
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.
The information, material and content contained in this transcript (“Content”) is for information purposes only and does not constitute advice of any type or a trade recommendation and should not form the basis of any investment decision.This transcript has been edited by Third Bridge for ease of reading. Third Bridge Group Limited and its affiliates (together “Third Bridge”) make no representation and accept no liability for the Contentor for any errors, omissions or inaccuracies in respect of it. The views of the specialist expressed in the Content are those of the specialist and they are not endorsed by, nor do they represent the opinion of, Third Bridge. Third Bridge reserves all copyright, intellectual and other property rights in the Content. Any modification, reformatting, copying, displaying, distributing, transmitting, publishing, licensing, creating derivative works from, transferring or selling any Content is strictly prohibited
